An observational study in Adverse Drug Event, sponsored by KK Women's and Children's Hospital. Completed. Open to participants aged 1 Month to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-25.
Sponsored by KK Women's and Children's Hospital · Observational
Ametop was introduced into the formulary as it was deemed more efficacious for intravenous cannulation compared to EMLA. However, the incidences of adverse reactions seemed to be higher compared to other studies. This lead to a prospective observational study to look at the incidence and severity of skin reactions following routine clinical application of Ametop.
Ametop was introduced into the formulary as it was deemed more efficacious for intravenous cannulation compared to EMLA. After several critical incidences of adverse reactions that occurred with its application, a departmental audit was carried out to look at the incidence and severity reactions with its application as well as its outcome on intravenous cannulation. The findings of the departmental audit showed that the incidence of adverse reactions seemed to occur more commonly compared to other studies.
A prospective observational study was carried out to look at the incidence and severity of skin reactions following routine clinical application of Ametop.
This study aims to achieve the following:
444 studies on the registry are indexed under Drug-Related Side Effects and Adverse Reactions; 77 are open to participants now.
This study's enrollment of 192 is below the median of 364 across 162 observational studies indexed under Drug-Related Side Effects and Adverse Reactions.
Browse Drug-Related Side Effects and Adverse Reactions studies →KK Women's and Children's Hospital is the lead sponsor of 137 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Paediatric patients presenting for surgery in KK Women's and Children's Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Application of Ametop prior to intravenous cannulation
Also known as: Ametop
Incidence of skin reactions with Ametop
looking at the incidence of skin reactions with Ametop - normal, simple erythema, raised erythema, itch, pallor
Time frame: October 2014 to May 2015
Risk factors associated with incidence of skin reactions
Looking at possible factors associated with skin reactions - race, duration of application, history of atopy
Time frame: October 2014 to May 2015
No study locations are listed for this record.
Plan to share: No — Data will be protected and not shared.
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Drug-Related Side Effects and Adverse Reactions →
KK Women's and Children's Hospital →